loader
Please Wait
Applying Filters...

Annual Sales of Rimegepant reported using PharmaCompass' compilation of Annual Reports of Global Pharmaceutical Companies.

Menu
$ API Ref.Price (USD/KG) : 35,178Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 2Nurtec ODT/Vydura

PharmaCompass

01

Brand Name : Nurtec ODT/Vydura

Rimegepant

arrow
Discovery on Target
Not Confirmed

02

Brand Name : Nurtec ODT/Vydura

Rimegepant

arrow
Discovery on Target
Not Confirmed

Brand Name : Nurtec ODT/Vydura

arrow
Discovery on Target
Not Confirmed

Rimegepant

Main Therapeutic Indication : Neurology

Currency : USD

2023 Revenue in Millions : 928

2022 Revenue in Millions : 213

Growth (%) : 336

blank